SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors focus on its strategic pivot into AI-ready network infrastructure and tactical defense partnerships, fueled by strong institutional accumulation and recent analyst upgrades. The community is actively debating the company's long-term transformation into an AI-data backbone and monitoring potential volatility leading into upcoming earnings.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The MELANIA crypto token is currently being discussed as a controversial asset, with the community actively debating whether it is a legitimate investment or a high-profile pump-and-dump scheme. Sentiment remains heavily polarized, as investors weigh significant historical price declines against ongoing speculation about potential political catalysts or upcoming project developments.

BlockDAG is a hybrid concept that combines features of both traditional blockchains and DAGs. It retains the benefits of DAGs, such as high scalability and faster transaction processing, while integrating the security and trust of blockchain consensus mechanisms. BlockDAG emerges as a groundbreaking solution, meticulously merging the strengths of both blockchain and DAG architectures. It leverages the robust security and decentralization of blockchains while incorporating the efficient, scalable transaction processing of DAGs. This strategic integration allows blockDAG to handle a significantly higher volume of transactions at faster speeds compared to traditional blockchains. By overcoming the inherent limitations of both technologies, blockDAG paves the way for a future where distributed ledgers can seamlessly scale to meet the ever-growing demands of the cryptocurrency and broader digital landscape.

BlockDAG

BlockDAG is currently facing intense scrutiny as investors report significant technical hurdles, including difficulties claiming tokens, disappearing balances, and confusion surrounding wallet compatibility. While some community members remain hopeful about the project's long-term potential and upcoming exchange integration, many are voicing frustration over the extended nature of the presale and unresolved access issues.

Fidelity Wise Origin Bitcoin Fund - Fidelity Wise Origin Bitcoin Fund Beneficial Interest

Fidelity Wise Origin Bitcoin Fund

The Fidelity Wise Origin Bitcoin Fund (FBTC) is trending as retail and institutional investors navigate market volatility, with the community actively debating whether to hold Bitcoin directly or rotate into spot ETFs to capture potential upside from a favorable regulatory climate and the anticipated U.S. strategic reserve. Discussions are dominated by strategies for accumulation, comparisons between ETFs like FBTC and IBIT, and a broader focus on Bitcoin's long-term potential amid shifting institutional demand.

Ankr is a Web3 decentralized infrastructure provider that helps developers, dapps, and stakers easily interact with multiple blockchains. It allows you to create DApps using API and RPC, staking on Ankr Earn, and use customized blockchain solutions for businesses.

Ankr Network

ANKR is currently facing intense community backlash, with investors expressing deep frustration over the token's stagnant performance despite broader market gains. While some holders continue to advocate for its underlying infrastructure potential and upcoming developments like Neura, a significant portion of the community describes the project as a "scam" and expresses anger over a perceived lack of developer communication and transparency.

NEOS ETF Trust - NEOS S&P 500 High Income ETF

NEOS S&P 500 High Income ETF

Investors are actively flocking to SPYI for its high monthly distribution yield and tax-efficient structure, viewing it as a stable income alternative to standard S&P 500 index funds. The community frequently highlights the fund's lack of price decay and consistent payouts as a reliable way to generate passive income while maintaining exposure to large-cap equities.

Purecycle Technologies, Inc. engages in recycling waste polypropylene into virgin polymer. Its process includes two steps: Feed Pre-Processing and the use of the Technology for purification. The company was founded by John Scott in September 2015 and is headquartered in Orlando, FL.

PureCycle Technologies Inc

PureCycle Technologies is seeing heightened community discussion as investors weigh the company's long-term potential in plastic recycling against significant operational hurdles and cash burn concerns. While the stock faces persistent short interest and frustration over delayed revenue conversion, proponents point to institutional support from major figures and upcoming expansion milestones in Thailand and Europe as key indicators of a structural, long-term opportunity.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is attracting attention due to its relentless, community-driven approach, which emphasizes building a long-term, multi-initiative brand beyond traditional crypto speculation. Supporters are actively using market pullbacks as an opportunity to stack their bags, citing the project's consistent real-world development and active community engagement as reasons for their continued conviction.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis is in the spotlight following the announcement of a multi-billion dollar investment plan to bolster its U.S. manufacturing operations and re-open key production facilities. Investors and the community are actively debating the company's turnaround efforts, focusing on shifting product strategies, management execution, and the long-term impact of these capital commitments on shareholder value.

Tidal Trust II - YieldMax Ultra Short Option Income Strategy ETF

Investors are actively utilizing SLTY within a systematic, inverted-pair strategy alongside ULTY to manage volatility and generate consistent weekly income. The community focus remains on mechanical, rules-based dividend compounding and ladder rotation to enhance share counts and mitigate the effects of underlying market price fluctuations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MDNAF A longtime holders sold and I can relate. He brought up a good point regarding MDNA11 vs THOR 707 so I thought I put this here.  I&#39;m surprised David (substack) didn&#39;t deep dive this more: 
 
THOR-707 (Sanofi) 
✔ First-generation engineered IL-2 without IL-2Rα binding 
✔ Showed expected immune bias in early trials 
❌ Lower potency and clinical efficacy than hoped; program discontinued 
 
MDNA11  
✔ Next-generation IL-2 superkine with enhanced IL-2Rβ affinity and albumin fusion 
✔ Demonstrates promising clinical responses and durable immune cell expansion 
✔ Favorable safety and dosing profiles 
✔ Still actively in Phase 1/2 development 
 
Bottom line: Both drugs share a common immuno-oncology strategy — leverage IL-2 signaling to stimulate anti-tumor immunity without triggering regulatory T cells and toxicities — but MDNA11’s enhanced receptor engagement and extended half-life appear to translate into stronger, more durable clinical activity compared with THOR-707’s earlier approach.

Tim The Enchanter

Aurinia Beach

Sean Beasley

Michael

rudazur

K Wong

Broc Segura

Karl Kozulka

StockTwits Web

Medicenna Therapeutics Corp

 A longtime holders sold and I can relate. He brought up a good point regarding MDNA11 vs THOR 707 so I thought I put this here.  I'm surprised David (substack) didn't deep dive this more: 
 
THOR-707 (Sanofi) 
✔ First-generation engineered IL-2 without IL-2Rα binding 
✔ Showed expected immune bias in early trials 
❌ Lower potency and clinical efficacy than hoped; program discontinued 
 
MDNA11  
✔ Next-generation IL-2 superkine with enhanced IL-2Rβ affinity and albumin fusion 
✔ Demonstrates promising clinical responses and durable immune cell expansion 
✔ Favorable safety and dosing profiles 
✔ Still actively in Phase 1/2 development 
 
Bottom line: Both drugs share a common immuno-oncology strategy — leverage IL-2 signaling to stimulate anti-tumor immunity without triggering regulatory T cells and toxicities — but MDNA11’s enhanced receptor engagement and extended half-life appear to translate into stronger, more durable clinical activity compared with THOR-707’s earlier approach.